Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Abbott
With
Orion Corporation, Orion Pharma
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
A written informed consent must be obtained for hospitalized male or female patients over 18 years old of age.
The eligible patients must be diagnosed with worsening heart failure as evidenced by dyspnea at rest, poor ejection fraction and have been treated with IV diuretics.
It is allowable for the patients to be treated with IV inotropes and vasodilators.
You may not be if
The following criteria would exclude the patient from study:
hepatic impairment (e.g. significant increase in liver enzymes),
decompensation from active infection and acute bleeding (e.g. severe anemia).
Female patients of child bearing potential must have a negative pregnancy test and use adequate contraceptive precautions.
Also excluded is the use of amrinone and milrinone prior to randomization, a history of hypersensitivity to levosimendan or any of the excipients and previous participation in a clinical trial with any experimental treatment within the last 30 days.
